Drug General Information
Drug ID	D06VMJ
Former ID	DCL001113
Drug Name	Melogliptin
Indication	Type 2 diabetes [ICD9: 250; ICD10:E11]		Phase 2	[548067]
Company	Glenmark pharma
Structure		Download 2D MOL 3D MOL
Target and Pathway
Target(s)	Dipeptidyl peptidase IV	Target Info	Inhibitor	[537022]
KEGG Pathway	Protein digestion and absorption
NetPath Pathway	IL2 Signaling Pathway
	TGF_beta_Receptor Signaling Pathway
References
Ref 548067	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021640)
Ref 537022	Emerging drug candidates of dipeptidyl peptidase IV (DPP IV) inhibitor class for the treatment of Type 2 Diabetes. Curr Drug Targets. 2009 Jan;10(1):71-87.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.